Oncocyte Signs Leading Transplant Centers in US and Germany

IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that its new customers include two leading transplant university hospitals in the U.S. and Germany. Both have entered into agreements with the Company to utilize GraftAssure™, the Company’s research-use-only assay (“GraftAssure”) that can detect early evidence of graft organ damage in patients’ blood.

Read more at globenewswire.com